AADI | Aadi Bioscience, Inc. | -37.68% | -32.26% | 0.00% | 94.39% | -93.19% | -0.50 |
---|
ABCL | AbCellera Biologics Inc. | -43.01% | -75.05% | 0.00% | 82.84% | -90.29% | -1.04 |
---|
ABCM | Abcam plc | -40.64% | -19.83% | 0.00% | 38.05% | -47.78% | -0.89 |
---|
ABEO | Abeona Therapeutics Inc. | -48.56% | -39.74% | 0.00% | 108.39% | -99.91% | -1.00 |
---|
ABIO | ARCA biopharma, Inc. | 9.30% | -38.92% | 0.00% | 155.96% | -99.97% | -0.60 |
---|
ABOS | Acumen Pharmaceuticals, Inc. | -46.01% | N/A | 0.00% | 72.19% | -84.81% | N/A |
---|
ABSI | Absci Corporation | -54.15% | N/A | 0.00% | 101.35% | -88.48% | N/A |
---|
ABUS | Arbutus Biopharma Corporation | -38.05% | 1.89% | 0.00% | 95.28% | -97.19% | -0.17 |
---|
ABVC | ABVC BioPharma, Inc. | -38.35% | -86.20% | 0.00% | 1,232.60% | -100.00% | -0.35 |
---|
ACAD | ACADIA Pharmaceuticals Inc. | -26.95% | 28.29% | 0.00% | 81.03% | -73.99% | -0.33 |
---|
ACER | Acer Therapeutics Inc. | -8.33% | -35.08% | 0.00% | 128.30% | -99.88% | -0.41 |
---|
ACET | Adicet Bio, Inc. | -29.56% | -40.87% | 0.00% | 95.69% | -95.80% | -0.11 |
---|
ACHL | Achilles Therapeutics plc | -53.09% | -82.20% | 0.00% | 75.17% | -89.03% | -1.12 |
---|
ACHV | Achieve Life Sciences, Inc. | -12.21% | -56.58% | 0.00% | 89.13% | -99.99% | -0.59 |
---|
ACIU | AC Immune SA | -37.37% | -24.98% | 0.00% | 78.09% | -86.84% | -0.76 |
---|
ACOR | Acorda Therapeutics, Inc. | -72.42% | -41.11% | 0.00% | 72.29% | -99.76% | -1.13 |
---|
ACRS | Aclaris Therapeutics, Inc. | -15.27% | 1.66% | 0.00% | 115.19% | -97.73% | -0.68 |
---|
ACXP | Acurx Pharmaceuticals, Inc. | -35.20% | N/A | 0.00% | 86.47% | -66.92% | N/A |
---|
ADAG | Adagene Inc. | -63.19% | -83.81% | 0.00% | 73.95% | -90.20% | -1.03 |
---|
ADAP | Adaptimmune Therapeutics plc | -58.13% | -28.13% | 0.00% | 118.13% | -96.57% | -0.95 |
---|